Evidence map›Paper›PMID 26557764›Full record

ArticleContemporary oncology (Poznan, Poland)2015

The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases.

Jacek Kowalski, Grażyna Cholewińska, Karolina Pyziak-Kowalska, Elżbieta Jabłonowska, Grażyna Barałkiewicz, Anna Grzeszczuk, Magdalena Leszczyszyn-Pynka, Anita Olczak, Maria Jankowska, Tomasz Mikuła and 3 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Jacek KowalskiHospital for Infectious Diseases in Warsaw, Warsaw, Poland.
Grażyna CholewińskaHospital for Infectious Diseases in Warsaw, Warsaw, Poland.
Karolina Pyziak-KowalskaHospital for Infectious Diseases in Warsaw, Warsaw, Poland.
Elżbieta JabłonowskaUniversity of Lodz, Lodz, Poland.
Grażyna BarałkiewiczPoznan University of Medical Sciences, Poznan, Poland.
Anna GrzeszczukMedical University of Bialystok, Bialystok, Poland.
Magdalena Leszczyszyn-PynkaPomeranian Medical University, Szczecin, Poland.
Anita OlczakNicolaus Copernicus University, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Maria JankowskaMedical University of Gdansk, Gdansk, Poland.
Tomasz MikułaMedical University of Warsaw, Warsaw, Poland.
Monika Bociąga-JasikJagiellonian University Medical College, Krakow, Poland.
Ewa Firląg-BurkackaMedical University of Warsaw, Warsaw, Poland.
Andrzej HorbanMedical University of Warsaw, Warsaw, Poland.
Medical University of Warsaw · PLGdańsk Medical University · PLJagiellonian University · PLMedical University of Białystok · PLNicolaus Copernicus University · PLPomeranian Medical University · PLPoznan University of Medical Sciences · PLUniversity of Łódź · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

the aim of the studyThe aim of the study was to evaluate the spectrum of AIDS-defining malignancies (ADMs) and non-AIDS-defining malignancies (NADMs) in HIV-infected patients in Poland. MATERIAL AND

methodsA retrospective observational study was conducted among HIV-infected adult patients who developed a malignancy between 1995 and 2012 in a Polish cohort. Malignancies were divided into ADMs and NADMs. Non-AIDS-defining malignancies were further categorised as virus-related (NADMs-VR) and unrelated (NADMs-VUR). Epidemiological data was analysed according to demographic data, medical history, and HIV-related information. Results were analysed by OR, EPITools package parameters and Fisher's exact test.

resultsIn this study 288 malignancies were discovered. The mean age at diagnosis was 41.25 years (IQR20-81); for ADMs 38.05 years, and for NADMs-VURs 46.42 years; 72.22% were male, 40.28% were co-infected with HCV. The risk behaviours were: 37.85% IDU, 33.33% MSM, and 24.31% heterosexual. Mean CD4+ at the diagnosis was 282 cells/mm(3) (for ADMs 232 and for NADMs-VUR 395). Average duration of HIV infection at diagnosis was 5.69 years. There were 159 (55.2%) ADMs and 129 (44.8%) NADMs, among whom 58 (44.96%) NADMs-VR and 71 (55.04%) NADMs-VUR. The most frequent malignancies were: NHL (n = 76; 26.39%), KS (n = 49; 17.01%), ICC (n = 34; 11.81%), HD (n = 23; 7.99%), lung cancer (n = 18; 6.25%) and HCC (n = 14; 4.86%). The amount of NADMs, NADMs-VURs in particular, is increasing at present. Male gender (OR = 1.889; 95% CI: 1.104-3.233; p = 0.024), advanced age: 50-60 years (OR = 3.022; 95% CI: 1.359-6.720; p = 0.01) and ≥ 60 years (OR = 15.111; 95% CI: 3.122-73.151; p < 0.001), longer duration of HIV-infection and successful HAART (OR = 2.769; 95% CI: 1.675-4.577; p = 0) were independent predictors of NADMs overall, respectively.

conclusionsIn a Polish cohort NHL was the most frequent malignancy among ADMs, whereas HD was the most frequent among NADMs. Increased incidence of NADMs appearing in elderly men with longer duration of HIV-infection and with better virological and immunological control was confirmed. As HIV-infected individuals live longer, better screening strategies, especially for NADMs-VUR, are needed. The spectrum of cancer diagnoses in Poland currently does not appear dissimilar to that observed in other European populations.

Indexed as

AIDS-defining malignanciescancercARTHIVnon-AIDS-defining malignanciesPLHIV

Identifiers

PMID26557764
PMCPMC4631280
OpenAlexW2215299756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.